New England Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.35M Hold
190,648
0.68% 50
2025
Q4
$4.75M Buy
190,648
+3,125
+2% +$78.8K 0.62% 52
2025
Q3
$4.78M Buy
187,523
+2,395
+1% +$59.1K 0.62% 51
2025
Q2
$4.49M Buy
185,128
+29,680
+19% +$692K 0.7% 50
2025
Q1
$3.94M Buy
155,448
+1,025
+0.7% +$26.8K 0.64% 56
2024
Q4
$4.1M Sell
154,423
-21,390
-12% -$580K 0.7% 52
2024
Q3
$5.09M Buy
175,813
+515
+0.3% +$15K 0.79% 47
2024
Q2
$4.9M Sell
175,298
-2,800
-2% -$77.1K 0.81% 45
2024
Q1
$4.94M Buy
178,098
+8,000
+5% +$222K 0.77% 49
2023
Q4
$4.9M Buy
170,098
+2,743
+2% +$82.9K 0.79% 47
2023
Q3
$5.55M Sell
167,355
-8,005
-5% -$283K 0.91% 40
2023
Q2
$6.43M Hold
175,360
0.93% 37
2023
Q1
$7.15M Sell
175,360
-7,770
-4% -$336K 1.07% 30
2022
Q4
$9.38M Sell
183,130
-4,778
-3% -$229K 0.17% 22
2022
Q3
$8.22M Buy
187,908
+9,028
+5% +$439K 0.14% 20
2022
Q2
$9.38M Buy
178,880
+1,100
+0.6% +$56.1K 0.16% 22
2022
Q1
$9.2M Buy
177,780
+2,700
+2% +$140K 0.15% 23
2021
Q4
$10.3M Buy
175,080
+6,150
+4% +$305K 0.16% 21
2021
Q3
$7.27M Buy
168,930
+10,553
+7% +$468K 0.13% 25
2021
Q2
$6.2M Buy
158,377
+1,995
+1% +$77.6K 0.11% 29
2021
Q1
$5.67M Buy
156,382
+2,400
+2% +$85.2K 0.11% 32
2020
Q4
$5.67M Sell
153,982
-5,364
-3% -$197K 0.11% 30
2020
Q3
$5.55M Sell
159,346
-4,321
-3% -$151K 0.13% 29
2020
Q2
$5.08M Sell
163,667
-10,856
-6% -$369K 0.12% 28
2020
Q1
$5.41M Buy
174,523
+9,222
+6% +$314K 0.13% 29
2019
Q4
$6.14M Sell
165,301
-2,213
-1% -$78.8K 0.1% 24
2019
Q3
$5.71M Hold
167,514
0.11% 30
2019
Q2
$6.88M Sell
167,514
-1,371
-0.8% -$54.4K 0.13% 22
2019
Q1
$6.8M Buy
168,885
+6,662
+4% +$267K 0.13% 21
2018
Q4
$6.72M Buy
162,223
+4,901
+3% +$203K 0.14% 22
2018
Q3
$6.58M Buy
157,322
+416
+0.3% +$16K 0.11% 23
2018
Q2
$5.4M Buy
156,906
+1,961
+1% +$67K 0.1% 22
2018
Q1
$5.22M Buy
154,945
+1,264
+0.8% +$43.5K 0.1% 20
2017
Q4
$5.28M Sell
153,681
-2,635
-2% -$89.8K 0.11% 22
2017
Q3
$5.29M Hold
156,316
0.12% 22
2017
Q2
$4.98M Sell
156,316
-2,293
-1% -$72.3K 0.16% 20
2017
Q1
$5.15M Buy
158,609
+34,642
+28% +$1.09M 0.08% 25
2016
Q4
$3.82M Sell
123,967
-15,547
-11% -$475K 0.11% 28
2016
Q3
$4.48M Buy
139,514
+738
+0.5% +$24.7K 0.17% 25
2016
Q2
$4.64M Sell
138,776
-949
-0.7% -$30.3K 0.17% 23
2016
Q1
$3.93M Buy
139,725
+7,906
+6% +$226K 0.12% 27
2015
Q4
$4.04M Sell
131,819
-66,373
-33% -$2.09M 0.1% 26
2015
Q3
$5.91M Sell
198,192
-13,615
-6% -$437K 0.15% 24
2015
Q2
$6.74M Buy
211,807
+53,649
+34% +$1.75M 0.17% 21
2015
Q1
$5.22M Buy
158,158
+50,723
+47% +$1.61M 0.13% 35
2014
Q4
$3.17M Sell
107,435
-52,513
-33% -$1.51M 0.08% 50
2014
Q3
$4.49M Sell
159,948
-15,341
-9% -$431K 0.11% 61
2014
Q2
$4.94M Buy
175,289
+1,635
+0.9% +$46.6K 0.12% 64
2014
Q1
$5.29M Sell
173,654
-2,002
-1% -$59.7K 0.13% 55
2013
Q4
$5.11M Buy
175,656
+2,424
+1% +$70.5K 0.13% 56
2013
Q3
$4.72M Buy
173,232
+24,347
+16% +$662K 0.14% 54
2013
Q2
$3.96M Buy
+148,885
New +$4.11M 0.12% 60

Other funds holding PFE

New England Asset Management's PFE Position: Q1 2026 in Review

New England Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 190,648 shares worth $5.35M. The position accounts for 0.68% of the portfolio, ranked #50.

New England Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.3M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • New England Asset Management held 190,648 shares of Pfizer worth $5.35M as of Q1 2026.
  • New England Asset Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.68% of New England Asset Management's portfolio in Q1 2026, its #50 holding.
  • New England Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • New England Asset Management's Pfizer position peaked at $10.3M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on New England Asset Management's 13F filing for Q1 2026, filed 15 May 2026.